GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7CDI | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD | |
7CDJ | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD | |
7CZV | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B | |
7D0B | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B | |
7D30 | P0DTC2 | Structure of sybody MR17-SR31 fusion in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) | |
7DEO | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
7DX4 | P0DTC2 | The structure of FC08 Fab-hA.CE2-RBD complex | |
7DX7 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound) | |
7E3L | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7EB0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2 | |
7JMO | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 | |
7JMP | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 | |
7JMW | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab | |
7JV4 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) | |
7JV6 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | |
7JVA | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | |
7JVC | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | |
7JW0 | P0DTC2 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | |
7JWY | P0DTC2 | Structure of SARS-CoV-2 spike at pH 4.5 | |
7JX3 | P0DTC2 | Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology | |
7JZL | P0DTC2 | SARS-CoV-2 spike in complex with LCB1 (2RBDs open) | |
7JZM | P0DTC2 | SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) | |
7JZN | P0DTC2 | SARS-CoV-2 spike in complex with LCB3 (2RBDs open) | |
7JZU | P0DTC2 | SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) | |
7K43 | P0DTC2 | SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment | |
7K45 | P0DTC2 | SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains) | |
7K4N | P0DTC2 | SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment | |
7K8M | P0DTC2 | Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 | |
7K8S | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1) | |
7K8T | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2) | |
7K8U | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104 | |
7K8V | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110 | |
7K8W | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119 | |
7K8X | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1) | |
7K8Y | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2) | |
7K8Z | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135 | |
7K90 | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144 | |
7K9Z | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52 | |
7KDH | P0DTC2 | SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | |
7KEB | P0DTC2 | SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | |
7KFW | P0DTC2 | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab) | |
7KFX | P0DTC2 | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab) | |
7KFY | P0DTC2 | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-F10 Fab) | |
7KLG | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033 | |
7KMB | P0DTC2 | ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4 | |
7KMH | P0DTC2 | LY-CoV488 neutralizing antibody against SARS-CoV-2 | |
7KMI | P0DTC2 | LY-CoV481 neutralizing antibody against SARS-CoV-2 | |
7KMK | P0DTC2 | cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound | |
7KML | P0DTC2 | cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound | |
7KMS | P0DTC2 | Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024